Tert-butyl (3R,4S)-3-phenyl-4-[(3-pyridin-4-yloxyphenyl)carbamoyl]pyrrolidine-1-carboxylate
C27H29N3O4 — CID 156839517
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl (3R,4S)-3-phenyl-4-[(3-pyridin-4-yloxyphenyl)carbamoyl]pyrrolidine-1-carboxylate
Tert-butyl (3R,4S)-3-phenyl-4-[(3-pyridin-4-yloxyphenyl)carbamoyl]pyrrolidine-1-carboxylate (PubChem CID 156839517) has the molecular formula C27H29N3O4 and a molecular weight of 459.55 g/mol. Its IUPAC name is tert-butyl (3R,4S)-3-phenyl-4-[(3-pyridin-4-yloxyphenyl)carbamoyl]pyrrolidine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl (3R,4S)-3-phenyl-4-[(3-pyridin-4-yloxyphenyl)carbamoyl]pyrrolidine-1-carboxylate |
|---|---|
| PubChem CID | 156839517 |
| Molecular Formula | C27H29N3O4 |
| Molecular Weight | 459.55 g/mol |
| Exact Mass | 459.22 |
| IUPAC Name | tert-butyl (3R,4S)-3-phenyl-4-[(3-pyridin-4-yloxyphenyl)carbamoyl]pyrrolidine-1-carboxylate |
| SMILES | CC(C)(C)OC(=O)N1C[C@@H](C(=O)Nc2cccc(Oc3ccncc3)c2)[C@H](c2ccccc2)C1 |
| InChI | InChI=1S/C27H29N3O4/c1-27(2,3)34-26(32)30-17-23(19-8-5-4-6-9-19)24(18-30)25(31)29-20-10-7-11-22(16-20)33-21-12-14-28-15-13-21/h4-16,23-24H,17-18H2,1-3H3,(H,29,31)/t23-,24+/m0/s1 |
| InChIKey | LHYKFEZWZPCIEJ-BJKOFHAPSA-N |
| XLogP | 5.46 |
| TPSA | 80.76 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 459.55 |
| LogP ≤ 5 | 5.46 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156839517 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.